๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa

โœ Scribed by Fabien Despas; A. Pathak; M. Berry; R. Cagnac; P. Massabuau; E. Liozon; M. Galinier; J. M. Senard

Publisher
Springer
Year
2010
Tongue
English
Weight
106 KB
Volume
20
Category
Article
ISSN
0959-9851

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term safety and efficacy of long-ac
Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients
โœ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 144 KB ๐Ÿ‘ 1 views

## Abstract This subgroup analysis of the 6โ€month, openโ€label Switch to Risperidone Microspheres (StoRMi) trial evaluated longโ€term safety and efficacy of a direct conversion to risperidone longโ€acting injectable (RLAI) in 52 elderly patients (โ‰ฅ65 years) with psychosis stabilized on oral or depot a

Efficacy and safety of long-acting rispe
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder
โœ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariรซlle Eerd ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 93 KB ๐Ÿ‘ 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Longโ€acting risperidone, the first longโ€acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi